CNDO-109-activated allogeneic natural killer cells
Term · Oncology and biomedicine · MLC-T-ONC-012685
A preparation of non-interleukin-2 primed, tumor activated allogeneic natural killer (NK) cells with potential immunostimulating activity. The allogeneic NK cells obtained from a first or second degree relative of the patient are co-incubated with a lysate from the CTV-1 cell line, a minimally differentiated myeloid line derived from an acute myelogenous leukemia patient. Infusion of CNDO-109-activated allogeneic NK cells may be able to lyse and destroy NK-resistant tumor cells and a broad spectrum of tumor cells.
| Identifier | MLC-T-ONC-012685 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CNDO-109-AANK cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012685",
"term": "CNDO-109-activated allogeneic natural killer cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of non-interleukin-2 primed, tumor activated allogeneic natural killer (NK) cells with potential immunostimulating activity. The allogeneic NK cells obtained from a first or second degree relative of the patient are co-incubated with a lysate from the CTV-1 cell line, a minimally differentiated myeloid line derived from an acute myelogenous leukemia patient. Infusion of CNDO-109-activated allogeneic NK cells may be able to lyse and destroy NK-resistant tumor cells and a broad spectrum of tumor cells.",
"synonyms": [
"CNDO-109-AANK cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cndo-109-activated-allogeneic-natural-killer-cells/"
}
Record 5,033 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.